			Home About us Contact

Pathophysiological Aspects (pathophysiological + aspect)

Distribution by Scientific Domains

Medical Sciences	100%

Selected Abstracts

Postprandial hyperglycaemia in type 2 diabetes: pathophysiological aspects, teleological notions and flags for clinical practice

DIABETES/METABOLISM: RESEARCH AND REVIEWS, Issue S2 2004
Eleni I. Boutati
Abstract Type 2 diabetes subjects carry an excess risk for micro- and macrovascular disease and a higher cardiovascular morbidity and mortality rate. The beneficial impact of tight glycaemic control,evidenced by the integrated marker of fasting glucose and postprandial glucose values, the HbA1c,for the prevention of microvascular complications is definitely confirmed. Over the past few years, several studies have identified postprandial hyperglycaemia as a better predictor of cardiovascular or even of all-cause mortality, as well as an independent risk factor for atherosclerosis. The continuous glucose monitoring could offer a rationale means for the detection of postprandial hyperglycaemia and ultimately for its effective management. Advances in technology keep a promise for a reliable, convenient and closer to the idea of the artificial endocrine pancreas glucose sensor. Subcutaneous glucose levels charted by one of the new sensors were found to be well correlated with venous glucose measurements. Intervention for a healthy lifestyle is frequently hampered by patients' poor compliance. The availability of diverse antidiabetic agents provides options for targeting the glycaemic goal and a choice more fitted to the particularized pathophysiology of each individual subject. Drugs targeting postprandial glycaemia may prove to represent the ,sine qua non' for the ,return' of postprandial glucose values at a ,non-deleterious' threshold, either as monotherapy for the early stages of the disease or as combination therapy later in the progression of diabetes. Copyright © 2004 John Wiley & Sons, Ltd. [source]

Exercise Training as a Therapy for Chronic Heart Failure: Can Older People Benefit?

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Issue 5 2003
Miles D. Witham BM
Despite recent advances in pharmacological therapy, chronic heart failure remains a major cause of morbidity and mortality in older people. Studies of exercise training in younger, carefully selected patients with heart failure have shown improvements in symptoms and exercise capacity and in many pathophysiological aspects of heart failure, including skeletal myopathy, ergoreceptor function, heart rate variability, endothelial function, and cytokine expression. Data on mortality and hospitalization are lacking, and effects on everyday activity, depression, and quality of life are unclear. Exercise therapy for patients with heart failure appears to be safe and has the potential to improve function and quality of life in older people with heart failure. To realize these potential benefits, exercise programs that are suitable for older, frail people need to be established and tested in an older, frail, unselected population with comorbidities. [source]

Experimental research and surgery: Why, how, and when?

MICROSURGERY, Issue 4 2001
Antonio Di Cataldo M.D.
Experimental research faces two great problems: the significant reduction of public funding and the firm opposition of the public opinion. The law forbids the use of large animals, so that it is possible to use small animals only, which require microsurgical techniques. However, even a skillful surgeon does not know how to perform microsurgery and has to begin a long and tiring training to master techniques. We think that experimental surgery should play a role because it tests the validity and safety of new surgical techniques and allows special pathophysiological aspects to be studied. Furthermore experimental surgery could represent an essential stage in the training of young surgeons. We should find a balance between observance of the law and respect of the animals and, on the other hand, the role of experimental surgery because we should not forget that its most important aim is the improvement of the health of the humankind. La ricerca sperimentale presenta delle difficoltà che dipendono in gran parte dalla scarsezza dei fondi ad essa destinati e dalla latente ostilità dell'opinione pubblica. Le leggi hanno ormai praticamente abolito la possibilità di utilizzare animali di grossa taglia per cui si possono impiegare solo piccoli animali, con la necessità di ricorrere a tecniche microchirurgiche, che non sono patrimonio di tutti i chirurghi, per cui per acquisirle bisogna sottoporsi a lunghi ed estenuanti tirocinii. Noi riteniamo che alla chirurgia sperimentale debba essere riconosciuto un suo ruolo per le possibilità che essa fornisce di saggiare la validità di nuove tecniche chirurgiche, di studiare particolari aspetti di fisiopatologia e di consentire un adeguato training dei giovani chirurghi. Sarebbe forse più giusto trovare un migliore equilibrio tra l'osservanza delle leggi ed il rispetto degli animali da un lato e la giusta collocazione della chirurgia sperimentale dall'altro, non dimenticando che quest'ultima ha come scopo unico ed esclusivo il miglioramento della salute dell'uomo. © 2001 Wiley-Liss, Inc. MICROSURGERY 21:118,120 2001 [source]

Basal ganglia physiology and deep brain stimulation,

MOVEMENT DISORDERS, Issue S1 2010
Andres M. Lozano FRCSC
Abstract Despite improvements in anatomic imaging of the basal ganglia, microelectrode recording is still an invaluable tool in locating appropriate targets for neurosurgical intervention. These recording also provide an unparalleled opportunity to study the pathophysiological aspects of diseases. This article reviews the principles of microelectrode recording in functional neurosurgery and discusses the pathologic neurophysiologic findings commonly encountered. It also highlights some of the potential mechanisms of action of both dopaminergic drugs and deep brain stimulation. In addition we review the recent work on pedunculopontine nucleus neurophysiology and trials of deep brain stimulation in that region for gait disturbances in Parkinson's disease. © 2010 Movement Disorder Society [source]

The intestinal barrier and its regulation by neuroimmune factors

NEUROGASTROENTEROLOGY & MOTILITY, Issue 7 2010
å. v. Keita
Abstract Background, The ability to control uptake across the mucosa and protect from damage of harmful substances from the lumen is defined as intestinal barrier function. A disturbed barrier dysfunction has been described in many human diseases and animal models, for example, inflammatory bowel disease, irritable bowel syndrome, and intestinal hypersensitivity. In most diseases and models, alterations are seen both of the paracellular pathway, via the tight junctions, and of the transcellular routes, via different types of endocytosis. Recent studies of pathogenic mechanisms have demonstrated the important role of neuroimmune interaction with the epithelial cells in the regulation of barrier function. Neural impulses from extrinsic vagal and/or sympathetic efferent fibers or intrinsic enteric nerves influence mucosal barrier function via direct effects on epithelial cells or via interaction with immune cells. For example, by nerve-mediated activation by corticotropin-releasing hormone or cholinergic pathways, mucosal mast cells release a range of mediators with effects on transcellular, and/or paracellular permeability (for example, tryptase, TNF-,, nerve growth factor, and interleukins). Purpose, In this review, we discuss current physiological and pathophysiological aspects of the intestinal barrier and, in particular, its regulation by neuroimmune factors. [source]